Previous Article | Next Article ![]()
Infect. Immun., 07 1997, 2663-2667, Vol 65, No. 7
MG Netea, PN Demacker, N de Bont, OC Boerman, AF Stalenhoef, JW van der Meer and BJ Kullberg
Recent studies have suggested the use of lipoproteins as an adjuvant
treatment of lethal gram-negative infections. However, other important
microorganisms for the etiology of sepsis, such as Candida species, grow
better in lipid-rich environments. We investigated the effect of
hyperlipoproteinemia on systemic candidiasis in low-density-lipoprotein-
receptor-deficient (LDLR-/-) mice, in which the loss of the receptor
results in a seven- to ninefold-higher plasma LDL level than that in their
wild-type littermates (C57BL/6J). LDLR-/- mice died earlier, and the
outgrowth of Candida albicans in the kidneys and livers of LDLR-/- mice was
significantly higher compared with that of controls. After infection,
circulating cytokine concentrations were significantly higher in LDLR-/-
mice. In vitro, C. albicans grew better in plasma samples of LDLR-/- mice
than in control plasma samples and peritoneal macrophages of LDLR-/- mice
challenged with heat-killed C. albicans produced more cytokines than did
those of controls. This latter phenomenon was probably due to increased
binding of yeast cells to macrophages of LDLR-/- mice. These data suggest
that hyperlipoproteinemia is deleterious in systemic candidiasis.
Copyright © 1997, American Society for Microbiology
Hyperlipoproteinemia enhances susceptibility to acute disseminated Candida albicans infection in low-density-lipoprotein-receptor- deficient mice
Department of Medicine, University Hospital Nijmegen, The Netherlands.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|